Author

A. Nomura-Kitabayashi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

H. Zhao· 2 shared L. Blanc· 2 shared P. Marambaud· 2 shared S. Ruiz· 2 shared C. Metz· 1 shared F. Campagne· 1 shared H. Choi· 1 shared J. Papoin· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

H. Zhao

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivSep 15, 2023

CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia

S. Dinakaran, H. Zhao, Y. Tang…·P. Marambaud

This study identifies CDK6-driven cell cycle acceleration in endothelial cells as a driver of arteriovenous malformations in HHT, suggesting CDK4/6 inhibitors as potential therapeutic options.

DOI 10.1038/s44161-024-00550-9

mousehuman

𝕏 PostBluesky

Cell BiologybioRxivPreprintAug 18, 2019

Sirolimus plus nintedanib treats vascular pathology in HHT mouse models

S. Ruiz, H. Zhao, P. Chandakkar…·P. Marambaud

This study shows that combining sirolimus and nintedanib treats vascular abnormalities in HHT mouse models by targeting multiple pathways.

DOI 10.1101/739144

mouseexperimental assay

𝕏 PostBluesky